HIV
In solidarity with the theme of the 2023 US Conference on HIV/AIDS, “A Love Letter to Black Women,” the HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP), led by its Director, Kaye Hayes, MPA, is creating a nationally coordinated, community-driven initiative to improve the lives and well-being of Black women of both cis and […]
Lifetime risk of acquiring HIV has decreased for Black gay and bisexual men in the US, from 1 in 2 from 2010 to 2014 to 1 in 3 from 2017 to 2021, according to data presented to the Conference on Retroviruses and Opportunistic Infections (CROI 2024) by researchers from the US Centers for Disease Control […]
HIV Statistics Impact on Racial and Ethnic Minorities AIDS.gov blog Source link
Justin Sullivan/Getty Images A study published by the New England Journal of Medicine showed that men who took the daily antiretroviral pill Truvada significantly reduced their risk of contracting HIV. CNN — After nearly a decade of working as an advocate for HIV and AIDS treatment, Michael Chancley said he came to a sobering realization. […]
Content From: HIV.govUpdated: November 13, 20233 min read TopicsGlobal HealthGlobal Health InitiativePEPFARPresident’s Emergency Plan for AIDS ReliefOIDPOffice of Infectious Disease and HIV/AIDS PolicyBidirectionalbi-directional learningOGAHHS Office of Global Affairs What is Global-Domestic Bidirectional HIV Work About? The U.S. government carries out its commitment to fostering excellence across all federally supported programs each day, including a focus […]
NEWARK, N.J. – The U.S. Attorney’s Office for the District of New Jersey and the U.S. Department of Health and Human Services Office for Civil Rights (HHS OCR) have secured a settlement agreement to resolve allegations that a home healthcare provider discriminated against a person with HIV. Comfort Hands Home Healthcare LLC (Comfort Hands) of […]
An influential expert panel has given its highest recommendation to an expanded menu of H.I.V. prevention strategies for adults and adolescents, a move that will require private insurers to cover the drugs without a co-pay or deductible under the Affordable Care Act. The recommendation arrives as the Biden administration is fighting to preserve no-cost coverage […]
– Journal Of Health Care for the Poor and Underserved Supplement Details COMPASS Progress at the Halfway Mark of the Ten-Year Initiative – FOSTER CITY, Calif. & NASHVILLE, Tenn.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) and Meharry Medical College, one of the nation’s oldest and largest historically Black academic health science centers, today announced the […]
– Biktarvy Evaluated in a Diverse Range of People With HIV, Including Pregnant Women and Pediatric Populations – – 96-Week Data from ALLIANCE Trial Show Durability of Biktarvy in Adults With HIV and HBV Coinfection – FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from multiple studies reinforcing Biktarvy® (bictegravir 50 […]